Stocks and securities in focus
| Security | Change (%) | 1w | 1m | 1y ▼ | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Insmed Inc. | -4.200% | -8.800% | 8.571% | 198.429% | 99.301% | 137.500% | 156.583% |
| Verastem Inc. | -7.350% | -9.353% | -27.586% | 167.943% | -66.623% | -93.652% | - |
| Savara Inc. | -1.000% | 4.211% | 2.591% | 37.500% | -8.333% | 197.744% | 66.003% |
| Ocular Therapeutix Inc. | -1.260% | -2.883% | 22.636% | 33.866% | 47.712% | -48.350% | 44.627% |
| Catalyst Pharmaceutical Partners Inc | -2.040% | -0.356% | -6.604% | 20.069% | -9.910% | 193.071% | 294.366% |
| G1 Therapeutics | 0.610% | 12.075% | -19.675% | 3.304% | -13.600% | -87.495% | - |
| Puma Biotechnology Inc. | -1.650% | -10.126% | -16.840% | -3.173% | -30.448% | -63.455% | - |
| Fate Therapeutics Inc. | -0.510% | -4.840% | -15.750% | -35.074% | -18.166% | -96.277% | - |
| Carisma Therapeutics Inc. | -6.830% | -25.662% | -2.112% | -86.245% | -61.095% | -98.619% | -98.156% |